Immune Globulin
• For over 50 years, IG was the only product for postexposure prophylaxis.
• Shown to be >85% efficacious.
• Several problems: -In countries where immune globulin was not used -In some countries vaccine is recommended over IG -In the UK, vaccine is recommend if it can be given early while IG is considered preferable later/for those with higher risk of serious outcome.
• In absence of studies directly comparing vaccine with immune globulin, Advisory Committee on Immunization Practices continues to recommend immune globulin for postexposure prophylaxis in the US.
Almaty, Kazakhstan: ~1.2 million residents
Hepatitis A occurs year round, but outbreaks involving large numbers of children occur annually in the fall and winter.
>95% of cases are hospitalized.
Primary Objective
To compare the efficacies of hepatitis A vaccine and IG in the prevention of laboratory-confirmed symptomatic hepatitis A when given within 14 days of exposure to a symptomatic index case of hepatitis A. 
Study Participants

Summary of Trial Results
• Efficacy of hepatitis A vaccine postexposure is quite high and similar to that of IG.
• Risk of hepatitis A for vaccine recipients was never >1.5% the risk for IG recipients.
• Some evidence that IG may attenuate clinical illness.
• No evidence that vaccine given in the second week after exposure resulted in lower clinical protection.
• Household contacts experienced the highest transmission rates. 
